SaRS-Cov-2 Antibodies Following Exposure to Coronavirus Disease 2019 (COVID-19) and/or Vaccination in Nursing Homes
NCT ID: NCT04964024
Last Updated: 2022-07-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1293 participants
OBSERVATIONAL
2021-07-15
2022-05-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Residents and health professionals in 9 nursing homes (NHs) with SaRS-Cov-2 antibodies detection after exposure (either COVID-19 or vaccine) All biological tests were performed in the frame of the standard care of residents and health professionals and all participants did not express opposition for using anonymously their data for the purpose of this academic analysis. In addition all Directors and Physicians of these NHs accepted to participate in this study
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
National Survey Concerning Vaccination Against COVID-19 in Nursing Homes and Long-Term Care Units
NCT04779541
2-year Mortality After COVID-19 in Nursing Home Residents
NCT06468761
Prevalence of COVID-19 in a French Dependent Care Facility for the Elderly and in a French Long-term Care Unit: Observational Study
NCT04872699
COVID-19 Seroconversion Among Front Line Medical and Paramedical Staff in Emergency, Intensive Care Units and Infectious Disease Departments During the 2020 Epidemic
NCT04304690
NOsocomial Dissemination Risk of SARS-Cov2
NCT04339881
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Residents in Nursing homes
SARS-CoV-2 antibodies
Analysis of the results of the serological response to COVID-19 and/or Vaccine
Health professionals in Nursing homes
SARS-CoV-2 antibodies
Analysis of the results of the serological response to COVID-19 and/or Vaccine
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SARS-CoV-2 antibodies
Analysis of the results of the serological response to COVID-19 and/or Vaccine
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Living in one of the 9 Nursing Homes that participate in this study
* Having a SARS-COV-2 post vaccination serology.
* Having no objection for using the results of the serology for the purpose of this analysis
For Health Professionals:
* Working in one of the 9 Nursing Homes that participate in this study,
* Having a SARS-COV-2 post vaccination serology.
* Having no objection for using the results of the serology for the purpose of this analysis
Exclusion Criteria
20 Years
110 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Central Hospital, Nancy, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pr Athanase BENETOS
Athanase Benetos, Clinical Professor, Head of the Dpt of Geriatrics
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHRU de Nancy, Université de Lorraine
Vandœuvre-lès-Nancy, US and Canada Only, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EHPAD-COVID-19
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.